Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $1.4 million.

  • Silo Pharma's Total Liabilities fell 2289.77% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 2289.77%. This contributed to the annual value of $2.4 million for FY2024, which is 5150.83% up from last year.
  • Latest data reveals that Silo Pharma reported Total Liabilities of $1.4 million as of Q3 2025, which was down 2289.77% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Silo Pharma's Total Liabilities peaked at $2.4 million during Q4 2024, and registered a low of $1.2 million during Q2 2022.
  • Over the past 5 years, Silo Pharma's median Total Liabilities value was $1.5 million (recorded in 2023), while the average stood at $1.6 million.
  • Per our database at Business Quant, Silo Pharma's Total Liabilities surged by 125023.39% in 2021 and then plummeted by 2289.77% in 2025.
  • Silo Pharma's Total Liabilities (Quarter) stood at $1.4 million in 2021, then fell by 8.81% to $1.3 million in 2022, then increased by 20.52% to $1.6 million in 2023, then soared by 51.51% to $2.4 million in 2024, then crashed by 42.13% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.7 million for Q2 2025, and $1.9 million during Q1 2025.